骨质疏松的防治-阿法迪三.pptVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* Risedronate is also available in low and high, daily or weekly doses as shown here. Administration guidelines are the same as for alendronate and include: Take risedronate on an empty stomach, first thing in the morning, with 8 ounces of tap water (no other liquid). Wait at least 30 minutes before eating or drinking and remain upright for at least 30 minutes after taking this medications. Side effects are uncommon and include upper gastrointestinal disorders including dysphagia, esophagitis and esophageal or gastric ulcer.1-2 1 Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.Osteoporos Int. 2000;11(1):83-91. 2 Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999 Oct 13;282(14):1344-52. * Calcitonin is another antiresorptive agent that can be used in osteoporosis treatment. Administration is as a nasal spray or injectable. * 让我们来看一下著名的PROOF试验结果。蓝色代表密盖息,黄色代表安慰剂。在安慰剂组203例患者中,发生椎体骨折的百分比为29.6%,而在200IU密盖息治疗组患者中,发生椎体骨折的百分比仅为19.3%。研究数据显示,对于既往曾发生过1-5次椎体骨折的患者,密盖息能够显著降低患者骨折危险性达36%。 Ref.2 * Side effects associated with nasally administered salmon calcitonin were found to be mild and of low incidence. Long-term administration of calcitonin in humans is associated with no serious or long-term side effects. Nasal spray calcitonin may cause nasal irritation and bloody or runny nose, as well as backache and headaches. Injected calcitonin may cause allergic responses, such as itching or redness and swelling at the inj

文档评论(0)

wxc6688 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档